Tom Rhys Harries Film Injury and Box Office Surge for Clayface

A torn anterior cruciate ligament remained hidden from the director and production crew until the final week of filming. Tom Rhys Harries, who plays Matt Hagen in the DC Studios horror film Clayface, concealed the injury to protect the role. The secret came out only after the star completed a sequence involving a high jump and a fall.

The film opened to strong financial results this week. It earned $46.5 million globally, surpassing its $44 million production budget. The performance marks a rare commercial success for a horror title from the franchise. Audience reception proved stronger than critical consensus, with the film holding a 94 percent score among verified moviegoers on Rotten Tomatoes. This stands in contrast to the 75 percent score from professional critics. The movie also received an A- CinemaScore, a grade seldom seen in the horror genre.

James Watkins, the British director, guided the project from development through post-production. He pitched the film to DC Studios co-chairs James Gunn and Peter Safran based on a description by original screenwriter Mike Flanagan. Flanagan called his draft "a tragedy in three acts." Watkins built his pitch around the physical and professional collapse of Matt Hagen. He envisioned a character whose face is disfigured by a mobster, ending an acting career that was just reaching new heights. Watkins noted that Gunn, an experienced horror fan, physically reacted to the body-horror concepts in the pitch.

The production faced a personal crisis in its final stages. Watkins learned of the sudden death of his father, Dr. George Watkins CBE, while editing was underway. Gunn and Safran granted Watkins the necessary time to address the family loss. They recently offered similar flexibility to producer Matt Reeves during a private crisis on a different project. Watkins described the support as essential. "James and Peter reached out and afforded me time and were very kind at a point when there was a film to finish. So I'll never forget that," he said.

The lead actor's injury added a layer of parallel narrative to the film's plot. Matt Hagen seeks an experimental procedure from Dr. Caitlyn Corr, played by Naomi Ackie. The treatment uses AI nanocells to repair his damaged tissue. The side effects trigger when Hagen experiences negative emotions. In one scene, his face melts at a movie premiere after he crashes the event to gloat over his former colleagues. Hagen returns to Corr's lab and overdoses on the nanite treatment. This decision transforms him into a volatile shapeshifter. The nanos in his blood exploit his lack of impulse control.

The story moves toward a tragic conclusion at a nightclub owned by the mob boss who initially disfigured Hagen. Watkins developed this set piece in later rewrites with Hossein Amini. The director wanted to capture the feeling of a classic revenge film. "I really wanted to beef up Matt's journey upstairs [to confront mobster Markos Szabo]. I kept talking about capturing the feeling of Robin Hood movies, or a film like El Cid, where they storm the castle," Watkins said. He aimed to let the audience enjoy the satisfaction of payback before the story shifts.

Hagen's quest for vengeance turns dark when he kills Detective John Borelli, played by Max Minghella. Borelli was attempting to secure legal justice for Hagen. The detective also faced a conflict of interest because Corr's untested procedure could implicate her if she arrested Hagen. Watkins explained that Hagen's actions stem from a combination of self-defense, love, and obsession driven by the nanobots. "The nanos are taking over him, and these primal impulses are bubbling up within him. From his point of view, it's explicable," Watkins said.

The film includes references to Tim Burton's 1989 Batman and a cameo by Aaron Paul. Watkins stated that the support from the DC Studios team allowed him to honor the original script while adapting it for production realities. He noted that scripts are living documents that evolve during filming and editing. The final cut reflects the collaboration between the director, the cast, and the studio executives.

The film is now in wide release. The combination of a strong opening weekend and high audience scores positions the title as a standout performance for the DC Studios slate.